Importantly, TMEM100 is also a potential downstream target of FOXF1 detected by ChIP-seq in mice overexpressing Foxf1 [53], suggesting that FOXF1 abnormalities may trigger expression changes of this gene in ACDMPV patients. This evidence concerns the gene FOXF1 and alveolar capillary dysplasia with misalignment of pulmonary veins.